Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Dosed in RGLS4326 Trial for Autosomal Dominant Polycystic Kidney Disease

americanpharmaceuticalreviewOctober 22, 2020

Tag: RGLS4326 , ADPKD , Regulus Therapeutics

PharmaSources Customer Service